Lv3
242 积分 2024-10-27 加入
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
4天前
已完结
Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
4天前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
7天前
已完结
Drug resistance in epilepsy
15天前
已完结
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers
15天前
已完结
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
16天前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
17天前
已完结
Complement in human disease: approved and up-and-coming therapeutics
20天前
已完结
Addressing Unmet Needs in Atopic Dermatitis: Evaluating Disease-Modifying Capabilities of Current and Emerging Therapies
24天前
已完结
Genetic and epigenetic regulation of inflammasomes: Role in atherosclerosis
1个月前
已完结
皖公网安备34019202002308
